Trials / Completed
CompletedNCT02877069
Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions
A Prospective, Single-arm Study of the Safety and Effectiveness of VYC-12 Hyaluronic Acid Injectable Gel for Treatment of Superficial Cutaneous Depressions Such as Fine Lines and for Improvement of Skin Quality
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and effectiveness of VYC-12 hyaluronic acid (HA) injectable gel for filling fine lines, as measured by skin texture improvement, and for improvement of skin quality.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VYC-12 HA injectable gel | VYC-12 Hyaluronic Acid (HA) injectable gel administered as an intradermal injection. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2016-01-01
- Completion
- 2016-10-01
- First posted
- 2016-08-24
- Last updated
- 2016-10-21
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02877069. Inclusion in this directory is not an endorsement.